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Regulation of cell proliferation by large-conductance calcium-activated potassium and 
volume-sensitive chloride channels in human cardiac fibroblasts 
ML He, CP Lau, HF Tse, GR Li
Department of Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong
Background: Cardiac fibroblasts play a central role in the maintenance of extracellular matrix in the normal 
heart and as mediators of inflammatory and fibrotic myocardial remodelling in the injured and failing heart. 
Excessive fibroblast proliferation and increase in the extracellular matrix increase myocardial stiffness and 
cause ventricular dysfunction and subsequent heart failure. Our previous study demonstrated that multiple 
ion channels were heterogeneously expressed in human cardiac fibroblasts, including IKCa (large-conductance 
calcium-activated potassium current), ICl.vol (volume-sensitive chloride current), and sodium current (INa). Little 
is known about the functional involvement of these ion channels in cardiac fibroblasts, and the present study 
was therefore designed to examine the possible involvement of these ion channels in proliferation of human 
cardiac fibroblasts. 
Methods and results: Using MTT assay and 3H-thymidine incorporation assay, we found that the INa current 
blocker tetrodotoxin had no effect on cell proliferation; however, the specific big conductance IKCa blocker 
paxilline (1 and 3 µM) and the volume-regulated chloride channel blocker 4,4’-diisothiocyanatostilbene-2,2’-
disulfonic acid disodium (DIDS, 100-200 µM) remarkably suppressed proliferation of human cardiac fibroblasts 
with 48 h incubation. Knockdown of KCa1.1 or CLC3 with specific siRNAs significantly reduced IKCa or ICl.vol 
channel protein levels, the cell proliferation was decreased by the corresponding siRNA. Flow cytometry 
analysis showed that human cardiac fibroblasts retained at G0/G1 phase (control, 55.8%) by paxilline (3 µM, 
79.2%, P<0.01) or DIDS (200 µM, 72.8%, P<0.05) or the corresponding siRNAs; meanwhile distribution of cells 
in S phase was decreased. Western blot analysis revealed a reduced expression of the cell cycle regulatory 
proteins cyclin D1 and cyclin E. 
Conclusion: Our results demonstrate that IKCa and ICl.vol channels, but not INa channels, participate in the 
regulation of proliferation of human cardiac fibroblasts by promoting cell cycle progression via modulating 
cyclin D1 and cyclin E expression.
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Treatment of endothelial progenitor cells dysfunction in patients with type 2 diabetes with 
human embryonic stem cells–derived endothelial progenitor cells
JCY Ho, WH Lai, MF Li, NLY Wong, MC Ip, KW Au, CW Siu, HF Tse 
Division of Cardiology, Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong
Introduction: Clinical studies suggest that endothelial progenitor cells (EPCs) can enhance angiogenesis and 
improve cardiac function in patients with myocardial ischaemia. However, the use of autologous EPCs therapy 
in those patients with diabetes is limited by the functional impairment in their EPCs. Recent advance in the 
availability of EPC derived from human embryonic stem cell (HES) could be a potential cell source to overcome 
the hurdles of the intrinsic scarcity and phenotypic deficiencies of EPCs.
Methods and Results: We investigated the cytokine profile and angiogenic potential of EPCs isolated from 
peripheral blood of type 2 diabetic patients (DM-EPC) and healthy controls (C-EPC). Cultured human umbilical 
vascular endothelial cells (HUVEC) and endothelial cells derived from HES (HES-EPC) were also assessed to 
evaluate their therapeutic potential. Furthermore, tube formation assay was performed to assess the in-vitro 
angiogenic potential of different source of EPCs. Using cytokine profiling, two angiogenic factors, vascular-
endothelial growth factor (VEGF, 197 vs 664 pg/mL; P<0.001) and angiogenin (418 vs 866 pg/mL; P<0.001) were 
shown to be down-regulated in DM-EPC compared with C-EPC. Tube formation assay revealed functional 
impairment of DM-EPCs which could be rescued by the replenishment of VEGF and angiogenin. More 
importantly, condition medium from cultured HES-EC, but not from HUVEC could also rescue the functional 
impairment of DM-EPC (P<0.05). When injected into the hind muscles in immunodeficient SCID mice subjected 
to unilateral ischaemia, CD34+CD31+ HES-EPC cells but not angiogenic factors cocktail improved limb salvage 
and haemodynamic (n=6, P<0.05).
Conclusion: Our results demonstrate that angiogenic factors secreted from HES-EPC can restore the function of 
EPCs in patients with type 2 diabetes, which can potentially improve the clinical efficacy of EPC therapy in those 
patients. 
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